Lee, Sujin
Nguyen, Minh Trang
Currier, Michael G.
Jenkins, Joe B.
Strobert, Elizabeth A.
Kajon, Adriana E.
Madan-Lala, Ranjna
Bochkov, Yury A.
Gern, James E.
Roy, Krishnendu
Lu, Xiaoyan
Erdman, Dean D.
Spearman, Paul
Moore, Martin L.
Article History
Received: 17 May 2016
Accepted: 5 August 2016
First Online: 22 September 2016
Competing interests
: M.L.M. co-founded and serves as Chief Scientific Officer for Meissa Vaccines, Inc. S.L., M.T.N. and M.L.M are co-inventors in a patent application (PCT/US2016/037658) describing the rhinovirus vaccine reported in this paper. The vaccine technology has been optioned to Meissa Vaccines, Inc. by Emory University. The remaining authors declare no competing financial interests.